help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maruyama, T.
Right arrow Articles by Ditzel, H. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maruyama, T.
Right arrow Articles by Ditzel, H. J.
(American Journal of Pathology. 2004;165:53-61.)
© 2004 American Society for Investigative Pathology

Molecular Analysis of the Human Autoantibody Response to {alpha}-Fodrin in Sjögren’s Syndrome Reveals Novel Apoptosis-Induced Specificity

Toshiaki Maruyama*, Ichiro Saito{dagger}, Yoshio Hayashi{ddagger}, Elizabeth Kompfner*, Robert I. Fox§, Dennis R. Burton* and Henrik J. Ditzel*¶||

From the Department of Immunology,* The Scripps Research Institute, La Jolla, California; the Allergy and Rheumatology Clinic,§ The Scripps Memorial Hospital, La Jolla, California; the Department of Pathology,{dagger} Tsurumi University School of Dental Medicine, Yokohama, Japan; the Department of Pathology,{ddagger} Tokushima University School of Dentistry, Tokushima, Japan; Center of Medical Biotechnology, Institute of Medical Biology, University of Southern Denmark, Odense, Denmark; and Department of Internal Medicine C,|| Odense University Hospital, Odense, Denmark

Lymphocyte infiltration of salivary and lacrimal glands leading to diminished secretion and gland destruction as a result of apoptosis is thought to be pivotal in the pathogenesis of Sjögren’s syndrome (SS). The cytoskeletal protein {alpha}-fodrin is cleaved during this apoptotic process, and a strong antibody (Ab) response is elicited to a 120-kd fragment of cleaved {alpha}-fodrin in the majority of SS patients, but generally not in other diseases in which apoptosis also occurs. Little is known about the anti-{alpha}-fodrin autoantibody response on a molecular level. To address this issue, IgG phage display libraries were generated from the bone marrow of two SS donors and a panel of anti-{alpha}-fodrin IgGs was isolated by selection on {alpha}-fodrin immunoblots. All of the human monoclonal Abs (hmAbs) reacted with a 150-kd fragment and not with the 120-kd fragment or intact {alpha}-fodrin, indicating that the epitope recognized became exposed after {alpha}-fodrin cleavage. Analysis of a large panel of SS patients (defined by the strict San Diego diagnostic criteria) showed that 25% of SS sera exhibited this 150-kd {alpha}-fodrin specificity. The hmAbs stained human cultured salivary acinar cells and the staining was redistributed to surface blebs during apoptosis. They also stained inflamed acinar/ductal epithelial cells in SS salivary tissue biopsies, and only partially co-localized with monoclonal Abs recognizing the full-length {alpha}-fodrin. Our study shows that in SS patients, neoepitopes on the 150-kd cleaved product of {alpha}-fodrin become exposed to the immune system, frequently eliciting anti-150-kd {alpha}-fodrin Abs in addition to the previously reported anti-120-kd Abs. The anti-150-kd {alpha}-fodrin hmAbs may serve as valuable reagents for the study of SS pathogenesis and diagnostic analyses of SS salivary gland tissue.





This article has been cited by other articles:


Home page
Ann. N. Y. Acad. Sci.Home page
T. WITTE, T. MATTHIAS, J. BIERWIRTH, and R. E. SCHMIDT
Antibodies against Alpha-Fodrin Are Associated with Sicca Syndrome in the General Population
Ann. N.Y. Acad. Sci., June 1, 2007; 1108(1): 414 - 417.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
P. Willeke, M. Gaubitz, H. Schotte, H. Becker, E. Mickholz, W. Domschke, and B. Schluter
Clinical and immunological characteristics of patients with Sjogren's syndrome in relation to {alpha}-fodrin antibodies
Rheumatology, March 1, 2007; 46(3): 479 - 483.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
M. Ramos-Casals and J. Font
Primary Sjogren's syndrome: current and emergent aetiopathogenic concepts
Rheumatology, November 1, 2005; 44(11): 1354 - 1367.
[Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
T. WITTE
Antifodrin Antibodies in Sjogren's Syndrome: A Review
Ann. N.Y. Acad. Sci., June 1, 2005; 1051(1): 235 - 239.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
L. Casciola-Rosen, K. Nagaraju, P. Plotz, K. Wang, S. Levine, E. Gabrielson, A. Corse, and A. Rosen
Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy
J. Exp. Med., February 22, 2005; 201(4): 591 - 601.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Society for Investigative Pathology.